Dr. Gulick and her collaborators at Psilera, Inc. were just awarded a small business research grant from the National Institute on Alcohol Abuse and Alcoholism. This grant will enable them to study Psilera's novel compounds as potential treatments for alcohol addiction with fewer side effects than canonical medications.